🔴Le programme d’accélération dédié à la santé des femmes #Tech4Eva a permis de lever 26,2 millions de dollars et 33,7 millions de dollars de promesses de transactions Ferring Pharmaceuticals Groupe Mutuel EPFL Innovation Park Aspivix @haplomind #startup agefi.com/actualites/ent…

Aspivix is thrilled to be attending & presenting at the first Swiss #Femtech Conference organized by @Tech4Eva! Discover the latest trends in Femtech and get insights from the experts. Don't miss the opportunity to register ➡️ lnkd.in/dJ2wHUcY #femtech #womenshealth

New program #Tech4Eva supports femtech entrepreneurs bit.ly/338Blnn via EPFL #Swisstech #VDtech cc EPFL Innovation Park Aspivix

Lucy Cohen's petition demanding better care in #IUD procedures gained global attention and prompted positive changes. We talked with Lucy about her story and why it is important to take female pain in #healthcare seriously. Discover more in our interview. ⬇️

Our CEO Mathieu Horras along with Lan Zuo Gillet, #Tech4Eva and Dr. Angele Gyet-Ageron, HUG were invited to the debate on RTS. We're proud to be involved in the discussion that continues to get momentum in #Switzerland and across the globe! bit.ly/3yQdogb

Great start to the new year! Thank you #Tech4Eva for covering Aspivix and highlighting its #mission. It has been an honor for us to be a part of an ecosystem advancing #womenshealthcare. Take a read! ⤵️ #gynecology #womenshealth #innovation

“I prefer to delay my IUD insertion until your product is available because I heard it hurts so much”. We received this statement today. Aspivix is working full force to accelerate our #product release so women do not have to wait to have their #IUD inserted. #gynecology #medtech

Meet Aspivix 🙌 2022 is a milestone year: We will proudly launch our flagship product and hopefully make a dent in #gynecology, moving #womenshealthcare forward. We invite you to come along and join us on this journey! bit.ly/3s0fSW8

We are thrilled to announce the enrollment completion of the Advance Women #clinicaltrial , a First in Women study comparing patient pain in #IUD insertion using Aspivix novel device vs. the standard of care. bit.ly/3I6l9Ck

27 months ago, Aspivix received a significant grant from the #Horizon2020 program. Today, our collaboration is coming to an end, so we want to extend a massive thanks to the European Research and Innovation Program initiated by the European Commission bit.ly/3t1cJWL

Aspivix hits yet another #milestone on its mission to advance #womenshealthcare ⤵️ linkedin.com/feed/update/ur…

Celebrating #IWD2022! We at Aspivix are committed to breaking the bias by empowering women's choices in #gynecology. It's time for patient-centric solutions in #womenshealthcare so women won't have to compromise when selecting effective #contraception. 👉bit.ly/3vOgz8M

clinicaltrialsarena.com/analysis/patie… The FDA recently released new guidance on how to involve patients in product development and #medicaldevice clinical trials. Hearing from end-users early in the process is the only way to bring #medical solutions that serve clinicians and patients alike.

A great deal has been said about painful patients´ experience during #IUD procedures. It is undeniable that #pain is a real problem, but what are the pain triggers during the procedure and what solutions are available? Learn more in our latest article! #aspivix #gynecology

In times of crisis, women lose access to #contraception. Nearly 50% of pregnancies are unintended and over 60% of unintended pregnancies end in abortion. A new #report by UNFPA calls on decision-makers to improve accessibility and contraception choices. bit.ly/3jsL8JB

Amélie Ebongué ☀️ Le domaine de la santé des femmes est malheureusement souvent tabou. Heuresement de nombreuses startups et entreprises de la femtech, notamment françaises, s'attaquent à ces problèmes : Aspivix, Perifit, Gynica, Bumpy...

CLINICAL DATA SHOW SIGNIFICANTLY LOWER IUD PROCEDURAL PAIN AND BLEEDING RATES WITH ASPIVIX'S NOVEL SUCTION-BASED C... prn.to/39SxbD7

clinical data show significantly lower iud procedural pain and bleeding rates with aspivix's novel SUCTION-BASED... iqstock.news/n/3951890/?utm… #bleed # safety # congress # healthcare # development # research # innovation # compelling results # comparative study # women worldwide

clinical data show significantly lower iud procedural pain and bleeding rates with aspivix’s novel SUCTION-BASED CERVICAL Device hngn.in/2022/05/25/cli…

Big thanks to EU Research Results - The Community Research and Development Information Service - for highlighting our work. cordis.europa.eu/article/id/436…